Amikacin Pharmacokinetics During Continuous Veno-Venous Hemodialysis

INTRODUCTION: Little is known about the pharmacokinetics of amikacin during continuous renal replacement therapy. METHODS: This prospective observational study included patients admitted to an academic medical center who received amikacin therapy while on continuous veno-venous hemodialysis (CVVHD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Simon W., Bauer, Seth R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108101/
https://www.ncbi.nlm.nih.gov/pubmed/25134484
http://dx.doi.org/10.1007/s40121-013-0012-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108101/
https://www.ncbi.nlm.nih.gov/pubmed/25134484
http://dx.doi.org/10.1007/s40121-013-0012-8

Ejemplares similares